The increasing spread of carbapenem-resistant Klebsiella pneumoniae represents a serious threat to public health and a major concern for clinicians. In K. pneumoniae, KPC is the most important determinant of carbapenem resistance owing to its distribution worldwide and to the high mortality rates associated with infections due to KPC-producing K. pneumoniae (KPC-Kp) strains
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates
Gaibani, Paolo;
2018-01-01
Abstract
The increasing spread of carbapenem-resistant Klebsiella pneumoniae represents a serious threat to public health and a major concern for clinicians. In K. pneumoniae, KPC is the most important determinant of carbapenem resistance owing to its distribution worldwide and to the high mortality rates associated with infections due to KPC-producing K. pneumoniae (KPC-Kp) strains
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gaibani et al IJIDmain.pdf
non disponibili
Licenza:
Accesso ristretto
Dimensione
293.39 kB
Formato
Adobe PDF
|
293.39 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
